celastrol has been researched along with Adverse Drug Event in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, M; Liu, C; Luo, Q; Qiu, F; Sun, X; Tao, Y | 1 |
| Chen, S; Jiang, HX; Liu, JQ; Liu, L; Liu, LF; Sun, Q; Zhang, L | 1 |
| Hou, W; Liu, B; Xu, H | 1 |
| Bross, P; Hansen, J | 1 |
1 review(s) available for celastrol and Adverse Drug Event
| Article | Year |
|---|---|
Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug-Related Side Effects and Adverse Reactions; Humans; Pentacyclic Triterpenes; Structure-Activity Relationship; Tripterygium; Triterpenes | 2020 |
3 other study(ies) available for celastrol and Adverse Drug Event
| Article | Year |
|---|---|
Screening of major hepatotoxic components of Tripterygium wilfordii based on hepatotoxic injury patterns.
Topics: Animals; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Mice; RNA, Messenger; Tripterygium; Tumor Necrosis Factor-alpha; Zebrafish | 2023 |
UPLC-Q-TOF-MS/MS-based urine metabolomics studies on the toxicity and detoxication of Tripterygium wilfordii Hook. f. after roasting.
Topics: Alkaloids; Amino Acids; Biomarkers; Drug-Related Side Effects and Adverse Reactions; Humans; Metabolomics; Tandem Mass Spectrometry; Tripterygium | 2023 |
A cellular viability assay to monitor drug toxicity.
Topics: Biological Assay; Cell Count; Cell Survival; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Formazans; Humans; Lymphocytes; Pentacyclic Triterpenes; Solubility; Time Factors; Triterpenes | 2010 |